Questions about the Evidence SummarySaturday, July 1, 2017 at 09:40am
These questions are regarding the Evidence Summaries we have available for each package: â€“ Does the signer role listed have to be unique regardless of a unique package? Example: Package1 â€“ signer1, signer2; Package2 â€“ signer3, signer4; etc and so on. Or does how we label the roles matter if its a unique package? â€“ This question probably ties into the last one I am guessing. We were looking at the â€œSigner IDâ€ on the evidence summary and curious what that is used for and how others may have used that with their integrations. What is its purpose? Would we need to store that value to be used (triage issues, etc)?